loader from loading.io

Julia Stalder: What DCIS and Hereditary Cancer Risk Share, From Uncertainty to Self-Advocacy

Walking the Genetic Line

Release Date: 11/19/2026

Julia Stalder: What DCIS and Hereditary Cancer Risk Share, From Uncertainty to Self-Advocacy show art Julia Stalder: What DCIS and Hereditary Cancer Risk Share, From Uncertainty to Self-Advocacy

Walking the Genetic Line

Episode summary Julia Stalder went in for a routine screening mammogram in February 2024 and came out on a path toward a diagnosis she had never heard of: ductal carcinoma in situ, or DCIS, sometimes called stage 0 breast cancer. Her genetic testing showed no predisposition, and she had little family history. What she found as she tried to understand her diagnosis was a gap. There were very few resources specific to DCIS, and the research couldn't yet say which cases would progress to invasive cancer and which might stay in the milk ducts for a lifetime. Julia sought three surgical opinions....

info_outline
Marisa Kimmel: Going Flat After a BRCA1 Diagnosis, and Defining Womanhood for Yourself show art Marisa Kimmel: Going Flat After a BRCA1 Diagnosis, and Defining Womanhood for Yourself

Walking the Genetic Line

Episode summary When Marisa Kimmel chose aesthetic flat closure after learning she carried a BRCA1 mutation, she wasn’t thinking about whether she would still feel like a woman. She was thinking about lowering her risk so she could stay alive for her six-month-old son. The question of femininity came later, handed to her by strangers on social media. Marisa had already done this work once. She was diagnosed with alopecia at nine, and years of trying to hold on to her hair took such a toll on her mental health that she came close to not wanting to be alive. Letting go of her hair taught her...

info_outline
Rachel Collier: Genetic Counseling Is More Than a Blood Draw, and Testing Is Always a Choice show art Rachel Collier: Genetic Counseling Is More Than a Blood Draw, and Testing Is Always a Choice

Walking the Genetic Line

Episode summary Many people walk into a genetic counseling appointment expecting a blood draw. Rachel Collier wants them to know there is far more available: education, informed consent, and real space to talk through what this information could mean for their lives. Because genetic results are information you can’t unlearn, she treats testing as a true choice, including the choice not to test. Rachel describes how hereditary cancer risk tends to become real in two phases, first in the initial appointment, when memories of relatives’ cancer treatment can resurface, and again when results...

info_outline
Randi Eichenbaum: BRCA2, Access to Care, and the birth of MOTA show art Randi Eichenbaum: BRCA2, Access to Care, and the birth of MOTA

Walking the Genetic Line

Episode summary Randi Eichenbaum was 19 when her mother died of ovarian cancer. Somewhere in those years she absorbed a quiet belief: this is going to happen to me too. Years later, a new OB-GYN recommended genetic testing based on her family history. The BRCA2 result came by phone from a third-party lab while she was at work, followed by an emailed PDF that no one walked her through. She put it in a drawer, literally and figuratively, and went back to work. What followed was a series of turning points. She became a mother and experienced acute postpartum anxiety. She had a prophylactic...

info_outline
Jaclyn Carnevale: From Cancer Diagnosis to Embryos Without the Mutation, A BRIP1 Previvor’s IVF Journey show art Jaclyn Carnevale: From Cancer Diagnosis to Embryos Without the Mutation, A BRIP1 Previvor’s IVF Journey

Walking the Genetic Line

Episode summary In May 2022, at 30 years old, Jaclyn found a lump in her breast. Her doctor, seeing no family history and a young, healthy patient, suggested she wait a week and see if it was still there. Jaclyn didn't take no for an answer — she asked for a mammogram, and within a single day learned she had DCIS, an early-stage breast cancer. What came next moved at a speed she describes as "medical timeline on fast forward": genetic counseling that flagged something didn't add up in her family's supposedly cancer-free history, a large genetic panel that turned up a mutation called BRIP1,...

info_outline
Kathy Baker: Founding My Faulty Gene & Surviving Hereditary Cancer show art Kathy Baker: Founding My Faulty Gene & Surviving Hereditary Cancer

Walking the Genetic Line

EPISODE SUMMARY Kathy Baker grew up in a family that, as she puts it, "looked like a poster for a BRCA mutation" — a sister diagnosed with breast cancer at 31, a mother with three primary cancers, a grandfather lost to aggressive prostate cancer, a great-grandmother lost to pancreatic cancer. And still, when genetic testing became available, Kathy said no. Not out of denial exactly, but out of a fierce instinct to protect her own life from being lived under a shadow. She was diagnosed with breast cancer herself in 2000, treated without ever seeing an oncologist first, and then spent nine...

info_outline
Elana Silber: The Chain You Inherit show art Elana Silber: The Chain You Inherit

Walking the Genetic Line

EPISODE SUMMARY Sharsheret is the Hebrew word for chain. Not a ribbon, not a fight, not a cure — a chain. Twenty-five years in, that name turns out to be the most precise available description of the work: over 40,000 people who have shared their experience, peer matches made not by mutation status but by the specific thing you are afraid of, social workers and genetic counselors who answer the phone, pre- and post-surgery kits arriving at the house wrapped and unbilled, and more than a million dollars a year moving quietly toward the non-medical costs that make a diagnosis expensive in ways...

info_outline
Holly Taylor: Hard-Earned Wisdom show art Holly Taylor: Hard-Earned Wisdom

Walking the Genetic Line

Episode Summary A visible tumor changed two lives at once. When Holly Taylor’s sister was diagnosed at 45 with simultaneous stage 3 ovarian and breast cancer — tumors large enough to see with the naked eye, discovered only after years of avoiding care without health insurance — genetic testing entered Holly’s life as an extension of her sister’s crisis rather than a decision of her own. An initial variant of unknown significance sat unresolved for two years before being reclassified as a pathogenic BRCA1 mutation, arriving in the middle of a four-and-a-half-year caregiving arc that...

info_outline
Marleah Dean Kruzel: You Make the Best Decision You Can — A Researcher’s Honest Take on BRCA and Uncertainty show art Marleah Dean Kruzel: You Make the Best Decision You Can — A Researcher’s Honest Take on BRCA and Uncertainty

Walking the Genetic Line

Guest: Marleah Dean Kruzel, PhD Theme: Uncertainty as a Lifetime Companion, Not a Problem to Solve Episode Summary Marleah Dean Kruzel was 8 years old when her mother found a lump. What followed were years of surgeries, chemotherapy, radiation, and a childhood lived largely in hospitals — experiences that eventually became the foundation of a research career dedicated to understanding what previvors actually go through, and what the systems meant to support them consistently fail to provide. She tested positive for BRCA2 in 2013, after letting the test kit sit in the back of her safe for...

info_outline
Natalie Samson Hart: How Integrative Genetic Counseling Changes What Comes Next show art Natalie Samson Hart: How Integrative Genetic Counseling Changes What Comes Next

Walking the Genetic Line

Guest: Natalie Samson Hart, MS, CGC, INHC Theme: Genetic Counseling as a Gateway to Whole-Person Care   Episode Summary Natalie Samson Hart didn’t come to oncology genetic counseling through a tidy career trajectory. She came through loss, confusion, and proximity to illness — a brother whose neurodivergence led her toward the intersection of science and human connection, a father diagnosed with stage 4 cancer while she was still in graduate school and rotating through cancer wards. That collision of the personal and professional is what eventually pushed her out of traditional...

info_outline
 
More Episodes

Episode summary

Julia Stalder went in for a routine screening mammogram in February 2024 and came out on a path toward a diagnosis she had never heard of: ductal carcinoma in situ, or DCIS, sometimes called stage 0 breast cancer. Her genetic testing showed no predisposition, and she had little family history. What she found as she tried to understand her diagnosis was a gap. There were very few resources specific to DCIS, and the research couldn't yet say which cases would progress to invasive cancer and which might stay in the milk ducts for a lifetime. Julia sought three surgical opinions. Rather than the mastectomy she was recommended, she chose active surveillance, a newer approach being studied in clinical trials, with close monitoring and the freedom to change course at any time. That process of learning, asking questions, and choosing became the foundation for DCIS Understood, the nonprofit she founded to bring evidence-based education and research funding to people facing this diagnosis.

This episode steps slightly outside hereditary cancer, but as Sara says, DCIS shares nearly every emotional and relational layer of the genetic risk experience. Both diagnoses hand people information about something that may or may not happen, then ask them to decide what to do with it. Sara and Julia explore how trauma history, the provider in the room, and access to time and insurance shape how that information lands. Sara names a hard truth for both communities: surgery is often chosen in hopes of finding peace, but there is no perfect solution, and recurrence anxiety and grief can remain either way. Julia offers a generous view of providers, who also have to sit with uncertainty, and a reminder that some patients simply want to be told what to do. Throughout, both return to the same place: decisions come from an emotional place, and that deserves respect, support, and integration.

We cover

  • Julia's DCIS diagnosis after a routine screening mammogram, and why it felt like it came out of nowhere

  • What DCIS is, as Julia describes it as a patient: abnormal cells in the milk ducts that have not spread into surrounding breast tissue

  • The lack of education and resources specific to DCIS, and how that gap led Julia to advocacy

  • Why the language of "stage zero," "pre-cancer," and "risk factor" creates confusion and fear

  • The emotional overlap between DCIS and carrying a hereditary cancer mutation

  • How trauma history, family stress, and past medical experiences shape how a diagnosis lands

  • Access to multiple opinions, and how insurance and location can limit patients' options

  • A provider's nervous system and how their way of holding uncertainty affects the patient

  • Julia's choice of active surveillance, with alternating mammograms and MRIs and low-dose hormone therapy

  • Why active surveillance isn't presented to most patients, and the importance of knowing your pathology

  • Julia's understanding of how widespread mammography changed the number of DCIS diagnoses

  • Questions about overtreatment, the side effects of surgery, radiation, and hormone therapy, and parallels with active surveillance in prostate cancer

  • Surgery as an attempt to find safety, and why recurrence anxiety often remains

  • Holding complexity and building a loving relationship with the frightened parts of ourselves

  • Grief after preventive mastectomy, remorse after waiting, and why neither has to mean the decision was wrong

  • Compassion for providers who also sit with uncertainty, and respect for patients who want a clear recommendation

  • How being a mother to her daughter motivates Julia to push DCIS research forward

  • How far breast cancer treatment has come, and how much further it can go

Highlights & takeaways

  • "It has given me so much agency around the diagnosis. And I think that has reduced my own trauma." For Julia, learning, seeking opinions, and building something from her experience changed how her diagnosis lived in her.

  • "What ultimately made me feel like my provider was the right one for me was that he acknowledged the uncertainty." A provider willing to say "we don't know yet" can make room for a patient's own decision.

  • Many people move quickly into surgery hoping it will bring peace and put the experience behind them. Sara offers a harder truth: there is no perfect solution, and the work is building the capacity to hold complexity with compassion.

  • "It wasn't the wrong decision, but we're making space for the sadness." Grief after a preventive surgery, or remorse after waiting, doesn't mean someone chose wrong.

  • "Decision making comes from an emotional place. That's not a bad thing." Sara names why mental health care belongs inside medical decision-making, not alongside it.

  • Not every patient wants to grapple with uncertainty. Julia reminds listeners that some people simply want a clear recommendation, and that is valid too.

Content note

This episode includes discussion of a breast cancer diagnosis, biopsies and imaging, treatment decisions including mastectomy, radiation, and hormone therapy, recurrence anxiety, medical trauma, references to histories of abuse, historical radical mastectomies, preventive mastectomy and grief about breastfeeding, and remorse following a cancer diagnosis.

Resources mentioned

Connect

If this conversation spoke to you, follow Walking the Genetic Line, rate and review the show, and share this episode with someone who has been handed a diagnosis that came with more questions than answers.

Connect with Sara Champie, LCSW at sarachampielcsw.com and on Instagram @SaraChampieLCSW.

Let’s walk this line, together.

Additional support

  • Therapy with Sara Champie, LCSW: Psychotherapy for people navigating breast cancer diagnoses, hereditary cancer risk, treatment decisions, and medical uncertainty. sarachampielcsw.com

  • Walking the Genetic Line Therapy and Support Group: A group space with Sara for people navigating hereditary cancer risk. https://www.sarachampielcsw.com/support-groups

  • DCIS Understood: Evidence-based education for people newly diagnosed with DCIS and their families. dcisunderstood.org